Literature DB >> 3020706

Brief overview of combination chemotherapy in non-small-cell lung cancer.

P Bonomi.   

Abstract

Entities:  

Mesh：

Year:  1986        PMID： 3020706

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  3 in total

1.  A randomized trial fo three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer Group.

Authors:  L Crino; M Tonato; S Darwish; M L Meacci; E Corgna; F Di Costanzo; F Buzzi; G Fornari; E Santi; E Ballatori
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

2.  A prognostic-factor risk index in advanced non-small-cell lung cancer treated with cisplatin-containing combination chemotherapy.

Authors:  T Shinkai; K Eguchi; Y Sasaki; T Tamura; Y Ohe; A Kojima; F Oshita; T Miya; H Okamoto; K Iemura
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

3.  Continuous carboplatin infusion during 6 weeks' radiotherapy in locally inoperable non-small-cell lung cancer: a phase I and pharmacokinetic study.

Authors:  H J Groen; A H van der Leest; E G de Vries; D R Uges; B G Szabó; N H Mulder
Journal:  Br J Cancer       Date:  1995-10       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.